These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 19309472

  • 1. A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus.
    Biggerstaff BJ, Petersen LR.
    Transfusion; 2009 Jun; 49(6):1151-9. PubMed ID: 19309472
    [Abstract] [Full Text] [Related]

  • 2. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing.
    Kleinman SH, Williams JD, Robertson G, Caglioti S, Williams RC, Spizman R, Morgan L, Tomasulo P, Busch MP.
    Transfusion; 2009 Jun; 49(6):1160-70. PubMed ID: 19320866
    [Abstract] [Full Text] [Related]

  • 3. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.
    Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, Busch MP.
    Transfusion; 2004 Nov; 44(11):1547-54. PubMed ID: 15504158
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. West Nile virus in 2006 and 2007: the Canadian Blood Services' experience.
    O'Brien SF, Scalia V, Zuber E, Hawes G, Alport EC, Goldman M, Fearon MA.
    Transfusion; 2010 May; 50(5):1118-25. PubMed ID: 20051051
    [Abstract] [Full Text] [Related]

  • 8. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.
    Busch MP, Tobler LH, Saldanha J, Caglioti S, Shyamala V, Linnen JM, Gallarda J, Phelps B, Smith RI, Drebot M, Kleinman SH.
    Transfusion; 2005 Apr; 45(4):492-9. PubMed ID: 15819668
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reacting to an emerging safety threat: West Nile virus in North America.
    Stramer SL.
    Dev Biol (Basel); 2007 Apr; 127():43-58. PubMed ID: 17486880
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. West Nile virus in Canadian blood donors.
    Cameron C, Reeves J, Antonishyn N, Tilley P, Alport T, Eurich B, Towns D, Lane D, Saldanha J.
    Transfusion; 2005 Apr; 45(4):487-91. PubMed ID: 15819667
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.
    Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
    [Abstract] [Full Text] [Related]

  • 17. In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.
    Rios M, Daniel S, Dayton AI, Wood O, Hewlett IK, Epstein JS, Caglioti S, Stramer SL.
    J Infect Dis; 2008 Nov 01; 198(9):1300-8. PubMed ID: 18771407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.